The recurrent TUBB3 Gly98Ser substitution is the first described to inconsistently result in CFEOM3.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
09 2020
Historique:
received: 09 03 2020
revised: 02 06 2020
accepted: 05 06 2020
pubmed: 25 7 2020
medline: 9 6 2021
entrez: 25 7 2020
Statut: ppublish

Résumé

Missense variants in TUBB3 have historically been associated with either congenital fibrosis of the extraocular muscles type 3 (CFEOM3) or malformations of cortical development (MCD). Until a recent report identified two amino acid substitutions in four patients that had clinical features of both disorders, pathogenic variants of TUBB3 were thought distinct to either respective disorder. Three recurrent de novo Gly71Arg TUBB3 substitutions and a single patient with a de novo Gly98Ser substitution blurred the MCD and CFEOM3 phenotypic distinctions. Here we report a second patient with a missense c.292G>A (p.Gly98Ser) substitution, but without CFEOM3, the first reported evidence that even the same TUBB3 substitution can produce a spectrum of TUBB3 syndrome phenotypes. Our patient presented with amblyopia, exotropia, optic disc pallor, and developmental delay. Neuroimaging identified hypoplasia of the corpus callosum, interdigitation of the frontal lobe gyri, and dysplasia or hypoplasia of the optic nerves, basal ganglia, brainstem, and cerebellum. This report identifies the TUBB3 Gly98Ser substitution to be recurrent but inconsistently including CFEOM3, and identifies the absence of joint contractures and the presence of optic disc abnormalities that may be genotype-specific to the TUBB3 Gly98Ser substitution.

Identifiants

pubmed: 32705776
doi: 10.1002/ajmg.a.61747
doi:

Substances chimiques

TUBB3 protein, human 0
Tubulin 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

2161-2167

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Bahi-Buisson, N., Poirier, K., Fourniol, F., Saillour, Y., Valence, S., Lebrun, N., … Chelly, J. (2014). The wide spectrum of tubulinopathies: What are the key features for the diagnosis? Brain, 137(Pt 6), 1676-1700. https://doi.org/10.1093/brain/awu082
Blumkin, L., Leibovitz, Z., Krajden-Haratz, K., Arad, A., Yosovich, K., Gindes, L., … Lerman-Sagie, T. (2020). Autosomal dominant TUBB3-related syndrome: Fetal, radiologic, clinical and morphological features. European Journal of Paediatric Neurology, 26, 46-60. https://doi.org/10.1016/j.ejpn.2020.03.001
Chew, S., Balasubramanian, R., Chan, W. M., Kang, P. B., Andrews, C., Webb, B. D., … Engle, E. C. (2013). A novel syndrome caused by the E410K amino acid substitution in the neuronal beta-tubulin isotype 3. Brain, 136(Pt 2), 522-535. https://doi.org/10.1093/brain/aws345
Cushion, T. D., Paciorkowski, A. R., Pilz, D. T., Mullins, J. G., Seltzer, L. E., Marion, R. W., … Dobyns, W. B. (2014). De novo mutations in the beta-tubulin gene TUBB2A cause simplified gyral patterning and infantile-onset epilepsy. American Journal of Human Genetics, 94(4), 634-641. https://doi.org/10.1016/j.ajhg.2014.03.009
Gronborg, S., Kjaergaard, S., Hove, H., Larsen, V. A., & Kirchhoff, M. (2015). Monozygotic twins with a de novo 0.32 Mb 16q24.3 deletion, including TUBB3 presenting with developmental delay and mild facial dysmorphism but without overt brain malformation. American Journal of Medical Genetics. Part A, 167A(11), 2731-2736. https://doi.org/10.1002/ajmg.a.37227
Lowe, J., Li, H., Downing, K. H., & Nogales, E. (2001). Refined structure of alpha beta-tubulin at 3.5 a resolution. Journal of Molecular Biology, 313(5), 1045-1057. https://doi.org/10.1006/jmbi.2001.5077
Oegema, R., Cushion, T. D., Phelps, I. G., Chung, S. K., Dempsey, J. C., Collins, S., … Doherty, D. (2015). Recognizable cerebellar dysplasia associated with mutations in multiple tubulin genes. Human Molecular Genetics, 24(18), 5313-5325. https://doi.org/10.1093/hmg/ddv250
Poirier, K., Saillour, Y., Bahi-Buisson, N., Jaglin, X. H., Fallet-Bianco, C., Nabbout, R., … Chelly, J. (2010). Mutations in the neuronal ss-tubulin subunit TUBB3 result in malformation of cortical development and neuronal migration defects. Human Molecular Genetics, 19(22), 4462-4473. https://doi.org/10.1093/hmg/ddq377
Romaniello, R., Arrigoni, F., Bassi, M. T., & Borgatti, R. (2015). Mutations in alpha- and beta-tubulin encoding genes: Implications in brain malformations. Brain Dev, 37(3), 273-280. https://doi.org/10.1016/j.braindev.2014.06.002
Shimojima, K., Okamoto, N., & Yamamoto, T. (2016). A novel TUBB3 mutation in a sporadic patient with asymmetric cortical dysplasia. American Journal of Medical Genetics. Part A, 170A(4), 1076-1079. https://doi.org/10.1002/ajmg.a.37545
Thomas, M. G., Maconachie, G. D. E., Constantinescu, C. S., Chan, W. M., Barry, B., Hisaund, M., … Gottlob, I. (2020). Congenital monocular elevation deficiency associated with a novel TUBB3 gene variant. The British Journal of Ophthalmology, 104(4), 547-550. https://doi.org/10.1136/bjophthalmol-2019-314293
Tischfield, M. A., Baris, H. N., Wu, C., Rudolph, G., Van Maldergem, L., He, W., … Engle, E. C. (2010). Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell, 140(1), 74-87. https://doi.org/10.1016/j.cell.2009.12.011
Whitman, M. C., Andrews, C., Chan, W. M., Tischfield, M. A., Stasheff, S. F., Brancati, F., … Engle, E. C. (2016). Two unique TUBB3 mutations cause both CFEOM3 and malformations of cortical development. American Journal of Medical Genetics. Part A, 170A(2), 297-305. https://doi.org/10.1002/ajmg.a.37362
Whitman, M. C., & Engle, E. C. (2017). Ocular congenital cranial dysinnervation disorders (CCDDs): Insights into axon growth and guidance. Human Molecular Genetics, 26(R1), R37-R44. https://doi.org/10.1093/hmg/ddx168

Auteurs

Scott C Smith (SC)

Human Genetics Laboratory, Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Ann Haskins Olney (AH)

Division of Genetic Medicine, Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Angela Beavers (A)

Department of Radiology, Children's Hospital, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Joanna Spaulding (J)

Human Genetics Laboratory, Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Marilu Nelson (M)

Human Genetics Laboratory, Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Shelly Nielsen (S)

Division of Genetic Medicine, Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Jennifer N Sanmann (JN)

Human Genetics Laboratory, Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH